Literature DB >> 15063897

Evaluation of the long term outcome of patients with extremity desmoids.

C Chew1, R Reid, P J O'Dwyer.   

Abstract

BACKGROUND: The optimum management and long-term outcome for patients with extremity desmoids remains unclear. The aim of this study was to evaluate the long-term outcome of patients with extremity desmoids and to compare patient episodes treated with surgery alone with those treated by radiotherapy either alone or with surgery at any stage of the patient's disease.
METHODS: All patients with extremity desmoids followed at an oncology clinic with an interest in soft tissue tumours and treated between 1959 and 1996 were identified. All were traced back to their primary presentation and first treatment episode.
RESULTS: During the study period 42 patients, 29 females and 13 males were identified. Median follow-up of the patient population was 12.5 years (range 3-30.9). Median age at presentation was 27 years (range 1-69). The lesion was in the upper limb or shoulder in 18, lower limp or pelvis 17 and head and neck 7. Forty patients underwent operation as their primary treatment, 25 of whom developed recurrent tumour. In all there were 41 recurrences following 78 episodes of surgery alone. This compared to 10 recurrences following 16 episodes of radiotherapy or radiotherapy with surgery (p = 0.467). There was no association between primary, first or second recurrence and the development of a further relapse. The median interval to recurrence after surgery alone was 12 months (interquartile range (IQR) 6-13) as opposed to 52 months (IQR 33-62) for patients treated with primary or adjuvant radiotherapy (p= 0.004).
CONCLUSION: Results are poor after both radiotherapy and surgery for extremity desmoids and research into other methods of managing this rare condition need to be considered.

Entities:  

Mesh:

Year:  2004        PMID: 15063897     DOI: 10.1016/j.ejso.2004.01.010

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  9 in total

Review 1.  A systematic review of active treatment options in patients with desmoid tumours.

Authors:  X Yao; T Corbett; A A Gupta; R A Kandel; S Verma; J Werier; M Ghert
Journal:  Curr Oncol       Date:  2014-08       Impact factor: 3.677

2.  Treatment and follow-up strategies in desmoid tumours: a practice guideline.

Authors:  M Ghert; X Yao; T Corbett; A A Gupta; R A Kandel; S Verma; J Werier
Journal:  Curr Oncol       Date:  2014-08       Impact factor: 3.677

3.  Aggressive fibromatosis of the neck initiated after thyroidectomy.

Authors:  S Arena; S Salamone; R Cianci; C Scollo; R Masucci; G Giannone; M Manusia; R Vigneri; G L La Rosa
Journal:  J Endocrinol Invest       Date:  2006-01       Impact factor: 4.256

4.  Desmoid Tumours of the extremity and trunk. A retrospective study of 44 patients.

Authors:  Laura Wirth; Alexander Klein; Andrea Baur-Melnyk; Thomas Knösel; Lars H Lindner; Falk Roeder; Volkmar Jansson; Hans Roland Dürr
Journal:  BMC Musculoskelet Disord       Date:  2018-01-05       Impact factor: 2.362

5.  Four different treatment strategies in aggressive fibromatosis: A systematic review.

Authors:  Jojanneke M Seinen; Maarten G Niebling; Esther Bastiaannet; Betty Pras; Harald J Hoekstra
Journal:  Clin Transl Radiat Oncol       Date:  2018-03-06

6.  Extra-Abdominal Desmoid-Type Fibromatosis Mimicking Myxofibrosarcoma.

Authors:  Ye Rin Kim; Yu Sung Yoon; Hyerim Park
Journal:  J Belg Soc Radiol       Date:  2022-09-21       Impact factor: 1.912

7.  Extra-abdominal desmoid tumours: a review of the literature.

Authors:  A P Molloy; B Hutchinson; G C O'Toole
Journal:  Sarcoma       Date:  2012-08-16

8.  Diagnosis and treatment of extraabdominal desmoid fibromatosis.

Authors:  Mohamed Ghanem; Antje Heinisch; Christoph-E Heyde; Georg Freiherr von Salis-Soglio
Journal:  GMS Interdiscip Plast Reconstr Surg DGPW       Date:  2014-02-24

9.  Chest wall desmoid tumours treated with definitive radiotherapy: a plan comparison of 3D conformal radiotherapy, intensity-modulated radiotherapy and volumetric-modulated arc radiotherapy.

Authors:  Jia Liu; Diana Ng; James Lee; Paul Stalley; Angela Hong
Journal:  Radiat Oncol       Date:  2016-03-02       Impact factor: 3.481

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.